Lisha Ying
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Inflammatory Biomarkers in Disease Prognosis
Papers in
-
- RNA modifications and cancer 3
- Oncology 20
- Pancreatic and Hepatic Oncology Research 6
- Cancer Immunotherapy and Biomarkers 4
- Inflammatory Biomarkers in Disease Prognosis 3
- Co-authors
- Dan Su (23 shared papers)Fanrong Zhang (13 shared papers)Junzhou Wu (11 shared papers)Kaiyan Chen (11 shared papers)Jiaoyue Jin (16 shared papers)Zhi‐Qiang Ling (3 shared papers)Weimin Mao (3 shared papers)Herbert Yu (9 shared papers)
- Journals
- Oncotarget (3 papers)Journal of Translational Medicine (2 papers)ACS Nano (2 papers)Annals of Surgical Oncology (2 papers)Cancer (1 paper)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Lisha Ying
41 papers receiving 781 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 229
- Oncology 371
- Pulmonary and Respiratory Medicine 233
- Molecular Biology 322
- Immunology 90
Countries citing papers authored by Lisha Ying
This map shows the geographic impact of Lisha Ying's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisha Ying with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisha Ying more than expected).
Fields of papers citing papers by Lisha Ying
This network shows the impact of papers produced by Lisha Ying. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisha Ying. The network helps show where Lisha Ying may publish in the future.
Co-authors
The 25 scholars most cited alongside Lisha Ying, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 92 | |
| 2 | 2012 | 71 | |
| 3 | 2017 | 66 | |
| 4 | 2016 | 56 | |
| 5 | 2013 | 56 | |
| 6 | 2021 | 42 | |
| 7 | 2012 | 39 | |
| 8 | 2016 | 39 | |
| 9 | 2016 | 35 | |
| 10 | 2017 | 26 | |
| 11 | 2019 | 25 | |
| 12 | 2015 | 17 | |
| 13 | 2018 | 17 | |
| 14 | 2012 | 17 | |
| 15 | ADP-ribosylation factor-like 4C (ARL4C), a novel ovarian cancer metastasis suppressor, identified by integrated genomics. | 2015 | 16 |
| 16 | 2024 | 15 | |
| 17 | 2017 | 14 | |
| 18 | 2016 | 13 | |
| 19 | 2015 | 13 | |
| 20 | 2020 | 12 |
About Lisha Ying
Lisha Ying is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Immunology, having authored 46 papers that have together received 788 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Cancer Genomics and Diagnostics (6 papers), Pancreatic and Hepatic Oncology Research (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), Esophageal Cancer Research and Treatment (4 papers), Ferroptosis and cancer prognosis (4 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (229 citations), Oncology (371 citations), Pulmonary and Respiratory Medicine (233 citations), Molecular Biology (322 citations) and Immunology (90 citations). Lisha Ying has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Dan Su, Fanrong Zhang, Junzhou Wu, Kaiyan Chen, Jiaoyue Jin, Zhi‐Qiang Ling, Weimin Mao, Herbert Yu, Guoping Cheng and Jianguo Feng. Their work appears in journals such as Oncotarget, Journal of Translational Medicine, ACS Nano, Annals of Surgical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.